Stay updated on CAB-AXL-ADC in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.

Latest updates to the CAB-AXL-ADC in Sarcoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2 in the page header. No substantive trial content or details were altered.SummaryDifference0.0%

- Check19 days agoChange DetectedThe revision label at the top of the page changes from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check27 days agoChange DetectedMinor UI and metadata updates include adding a glossary option and a revision label (v3.4.0) with slight capitalization changes; these changes do not modify core study content, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedAdded a 'Last Update Posted' label and removed the 'Last Update Posted (Estimated)' label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4, reflecting an internal version change.SummaryDifference0.0%

- Check63 days agoChange DetectedA consolidated Locations section listing all participating sites by state/country was added and the page revision updated to v3.3.3; individual state location entries and the HHS Vulnerability Disclosure link were removed.SummaryDifference2%

Stay in the know with updates to CAB-AXL-ADC in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.